Brain & Behavior

Syndicate content
Updated: 13 weeks 9 hours ago

Statins may exert influence on prostate cancer growth by reducing inflammation

Sat, 04/25/2009 - 9:30pm

DURHAM, N.C. - Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.

Drinking diet soda may reduce the risk of forming kidney stones

Sat, 04/25/2009 - 9:30pm

LINTHICUM, MD, April 26, 2009--Patients with stone disease could benefit from drinking diet soda. New research from the University of California, San Francisco suggests that the citrate and malate content in commonly consumed sodas may be sufficient to inhibit the development of calcium stones.

Tadalafil may effectively treat symptoms of BPH-LUTS in addition to erectile dysfunction

Sat, 04/25/2009 - 9:30pm

LINTHICUM, MD, April 26, 2009-Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonia and Indianapolis will present these findings during the 104th Annual Scientific Meeting of the American Urological Association (AUA).

Generics less effective/safe than branded medications in treating LUTS

Sat, 04/25/2009 - 9:30pm

LINTHICUM, MD, April 26, 2009-Men taking generic drugs may be more likely to have less effective results and more adverse events than if they were using branded medications, according to new data from researchers in New York.

New active surveillance parameters allow for more individualized patient care

Sat, 04/25/2009 - 9:30pm

LINTHICUM, MD, April 26, 2009-Active surveillance may be a viable option for some men, but reclassification of disease risk over time is imperative to ensure outcomes, according to researchers in Toronto, who will present these criteria during the 104th Annual Scientific Meeting of the American Urological Association (AUA).

Fistula-related morbidity decreased by prompt treatment in Sierra Leone

Sat, 04/25/2009 - 9:30pm

LINTHICUM, MD, April 26, 2009-Extent of fibrosis is the most profound factor in predicting surgical outcomes of genitourinary fistula repair, suggesting that prompt treatment could significantly improve survival. Researchers in Nashville review experiences at two centers in Sierra Leone to assess factors predictive of successful fistula repair.

Autologous muscle-derived cells may treat stress urinary incontinence

Sat, 04/25/2009 - 9:30pm

LINTHICUM, MD, April 26, 2009-Researchers have confirmed that transplanting autologous muscle-derived cells (AMDC) into the bladder is safe at a wide range of doses and significantly improves symptoms and quality of life in patients with stress urinary incontinence.

Does a person's insurance coverage affect their access to quality cancer care?

Fri, 04/24/2009 - 10:30pm

CHICAGO (April 26, 2009)--Does a person's insurance coverage affect their access to quality cancer care? According to researchers at Fox Chase Cancer Center, insurance coverage may not only affect a patient's access to health care, but also the quality of care they receive.

Can middle class families make urban schools better?

Fri, 04/24/2009 - 2:30pm

Due to the economy, more middle-class families are passing on private schools in favor of the local public school.

Run! It's the student council president

Fri, 04/24/2009 - 12:30pm

In most movies about high school, the student council president, the so-called "band geek" or the kid who stays after school for math club often fall victim to the teasing and bullying of the popular students or "jocks."

Landmark study demonstrates Gamunex improves health-related quality of life in patients with CIDP

Fri, 04/24/2009 - 11:30am

RESEARCH TRIANGLE PARK, N.C. (April 23, 2009) -- Talecris Biotherapeutics, Inc. today announced the publication of the health-related quality of life results from the largest clinical trial ever conducted in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) in the April 14, 2009 issue of Neurology.

Mind over muscle

Fri, 04/24/2009 - 8:30am

One in five women between the ages of 18 and 24 are smokers, and most say they keep lighting up for fear of gaining weight. But researchers at Temple University have found that when it comes to quitting, a little bit of dialogue and support can be more effective than an exercise plan in helping women not only keep off the weight, but also stay smoke-free.

Two-pronged model could help foil tough cystic fibrosis infections

Fri, 04/24/2009 - 8:30am

Hanover, NH--Dartmouth Medical School researchers have devised a novel approach for thwarting the relentless bacterial infections that thrive in the lungs of people with cystic fibrosis (CF), unlocking new possibilities against a tenacious and toxic hallmark of the common genetic disease.

Evolution of human sex roles more complex than described by universal theory

Fri, 04/24/2009 - 8:30am

A new study challenges long-standing expectations that men are promiscuous and women tend to be more particular when it comes to choosing a mate.

Levees cannot fully eliminate risk of flooding to New Orleans

Fri, 04/24/2009 - 7:30am

WASHINGTON -- Levees and floodwalls surrounding New Orleans -- no matter how large or sturdy -- cannot provide absolute protection against overtopping or failure in extreme events, says a new report by the National Academy of Engineering and the National Research Council.

Researchers find drug that inhibits acute leukemia cell growth

Fri, 04/24/2009 - 7:30am

SAN DIEGO - Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered how to turn off a certain receptor that promotes the growth of leukemia cells. The pre-clinical study was presented today in a platform session at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO).

Survival rates for cancer rise across Ireland

Fri, 04/24/2009 - 6:30am

Survival rates for cancer are continuing to rise even though the number of cases being diagnosed is increasing, an all-Ireland report launched today reveals.

Biolex presents Locteron US Phase 2a hepatitis C data at EASL

Fri, 04/24/2009 - 6:30am

Biolex Therapeutics, Inc. announced that the results from its United States Phase 2a clinical trial (the "PLUS" trial) of Locteron(R) will be presented today at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) in Copenhagen, Denmark.

Hydrogen protects nuclear fuel in final storage

Fri, 04/24/2009 - 6:30am

When Sweden's spent nuclear fuel is to be permanently stored, it will be protected by three different barriers. Even if all three barriers are damaged, the nuclear fuel will not dissolve into the groundwater, according to a new doctoral dissertation from Chalmers University of Technology in Sweden.

Texas has more farms, fewer acres, new study shows

Thu, 04/23/2009 - 2:30pm

COLLEGE STATION - The loss and fragmentation of Texas' farms, ranches and forests is part of a continued trend that highlights the importance of rural lands in maintaining the state's natural resources and economic base, according to a newly released study.